Terry Fisher, PhD

Investigator
Vaccinex, Inc, United States

Presentation(s):

• 38: Semaphorin 4D is Expressed by Activated Lymphocytes in Pancreatic Adenocarcinoma, and Monoclonal Blockade Sensitizes Murine Tumors to Immune Checkpoint Therapy

  Thursday, March 23, 2023
  10:26 AM – 10:36 AM

  Disclosure information not submitted.

• 55: Neoadjuvant Pepinemab in Combination with Nivolumab and/or Ipilimumab in Resectable Stage III Melanoma

  Friday, March 24, 2023
  10:04 AM – 10:14 AM

  Disclosure information not submitted.